| GALAPAGOS N.V. |
| Belgien |
| Gesundheit |
| BE0003818359 / A0EAT9 |
| GXE (Frankfurt) |
| FRA:GXE, ETR:GXE, GXE:GR |
| AEX |
| https://www.glpg.com/ |
|
Galapagos NV is a fully integrated biotechnology c..
>Volltext.. |
| 1839.28 Mio. EUR |
| -1204.57 Mio. EUR |
| 286 Mio. EUR |
| - |
| -434.56 Mio. EUR |
| -6.59 EUR |
| 7.48 Mio. EUR |
| 64.25 Mio. EUR |
| -199.36 Mio. EUR |
| 8.32 |
| -47.25% |
| -184.81% |
| - |
| - |
| - |
| - |
| GALAPAGOS |
| 27.12.25 |
|